PETALUMA, Calif.--(BUSINESS WIRE)--Oculus Innovative Sciences, Inc. (Nasdaq: OCLS), a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, which is intended to treat infections in chronic and acute wounds, announced today the company is sponsoring the RID symposium entitled “Essential Research on Preventing Hospital Infections,” which is being presented by RID President Dr. Betsy McCaughey on Friday, March 20 at 7 p.m. at the Sheraton San Diego Hotel & Marina. The RID symposium is presented in conjunction with the 2009 Annual Scientific Meeting of the Society for Healthcare Epidemiology of America (SHEA) that is being held at the same venue on March 19-22, 2009.
